Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Serono, Pfizer deal

PFE paid SEO $200 million to co-promote in the U.S. Rebif interferon beta-1a

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE